Side-by-side comparison of AI visibility scores, market position, and capabilities
Saint Paul MN water treatment and hygiene (NYSE: ECL) $15.7B FY2024 revenue (+5% organic); 25K+ field associates, food safety, data center cooling water treatment opportunity competing with Nalco/Dow and Diversey.
Ecolab Inc. is a Saint Paul, Minnesota-based water treatment, hygiene, and infection prevention company — publicly traded on the New York Stock Exchange (NYSE: ECL) as an S&P 500 Materials component — providing products, equipment, and services for cleaning, sanitizing, water treatment, and infection prevention to food processing plants, restaurants, hotels, hospitals, commercial laundries, power plants, and industrial facilities through approximately 47,000 employees ("associates") in 170 countries. In fiscal year 2024, Ecolab reported revenues of $15.7 billion (+5% organic growth) with record operating income and adjusted diluted EPS growth as the company benefited from pricing actions implemented in 2022-2023 to recover raw material cost inflation, while raw material costs normalized — creating margin expansion on pricing that persisted after input costs declined. CEO Christophe Beck has positioned Ecolab's growth strategy around three secular demand themes: water scarcity (food processing and industrial companies reducing water consumption per unit of output through Ecolab's water recycling and closed-loop treatment chemistry), food safety (food processors and restaurants requiring validated sanitization programs that meet FDA FSMA regulatory requirements for pathogen control), and infection prevention (healthcare facilities requiring hospital-grade disinfectants, surgical scrubs, and environmental hygiene programs that comply with CDC and Joint Commission standards). Ecolab's three divisions — Institutional & Specialty (restaurants, hotels, laundry — $7B+ revenue), Industrial (food processing, beverage, pharma, water treatment — $5B+ revenue), and Healthcare & Life Sciences ($1.5B+ revenue) — serve complementary end markets with differentiated chemistry and service programs.
Indianapolis agricultural seeds and crop protection (NYSE: CTVA) $17.2B FY2024 revenue; Pioneer Hi-Bred seeds, Enlist weed system, Qrome corn traits, competing with Bayer Crop Science and Syngenta.
Corteva, Inc. is an Indianapolis, Indiana-based agricultural science company — publicly traded on the New York Stock Exchange (NYSE: CTVA) as an S&P 500 Materials component — developing and selling seeds (Pioneer brand corn, soybean, sunflower, and vegetable seeds) and crop protection products (herbicides, insecticides, fungicides under Enlist, Instinct, Zorvec, and other brands) to farmers across 140 countries through approximately 22,000 employees. Corteva was spun off from DowDuPont in June 2019 as the agricultural science component of the DowDuPont three-way breakup (materials science → Dow Inc., specialty products → DuPont de Nemours, agriculture → Corteva), combining the Pioneer Hi-Bred seed genetics legacy (acquired by DuPont in 1999 for $9.4 billion) with the Dow AgroSciences crop protection portfolio. In fiscal year 2024, Corteva reported revenues of $17.2 billion, with the Seed segment (corn, soybean, and specialty crop seeds) generating $9.3 billion and the Crop Protection segment (pesticides, herbicides, fungicides) generating $7.9 billion — though crop protection faced market headwinds from generic agrochemical price competition and grower inventory destocking as global commodity crop prices fell from 2022-2023 peaks. CEO Chuck Magro's strategy focuses on driving pricing power through genetic trait performance (Corteva's Qrome corn trait technology delivering 5-10 bushel/acre yield advantage driving premium seed pricing) and the Enlist weed control system (herbicide-tolerant soybeans paired with Enlist Duo herbicide through a closed IP system that bundles herbicide and trait royalty revenue).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.